Using publicly available RNA sequencing data profiles, including more than 500,000 single cells from 15 AML patients and tissues from 9 healthy patients, investigators computationally identified 2 potential new targets, CSF1R and CD86. The gene discussed is CD86; the disease is acute myeloid leukemia.